2m 2m 2m 2m 2m 2m 2m
TRISALS LIFE SCI (TLSI)
NASDAQ
$3.17-$0.17 (-5.10%)
Price as of Jun 03, 2026 7:55 PM EDT- $209.4MMarket Cap
- -35.74%1-Year Change
- Medical DevicesIndustry
TRISALS LIFE SCI (TLSI)
$3.17-$0.17 (-5.10%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FIRST LIGHT ASSET MANAGEMENT, LLC | 13.37% | 5.1M | +5.1M (+100.00%) | Mar 31, 2026 |
AWM INVESTMENT COMPANY, INC. | 5.48% | 2.1M | +835,325 (+40.18%) | Mar 31, 2026 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 5.46% | 2.1M | 0 (0.00%) | Mar 31, 2026 |
VANGUARD GROUP INC | 4.04% | 1.5M | +371,132 (+24.25%) | Dec 31, 2025 |
BLACKROCK, INC. | 3.96% | 1.5M | -34,789 (-2.32%) | Mar 31, 2026 |
WASATCH ADVISORS LP | 3.79% | 1.4M | +1.4M (+100.00%) | Mar 31, 2026 |
N/A | 3.55% | 1.3M | +1.3M (+100.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
WASATCH FUNDS TRUST | 3.76% | 1.4M | +1.4M (+100.00%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 3.39% | 1.3M | +194,415 (+15.12%) | Mar 31, 2026 |
iSHARES TRUST | 2.54% | 963,680 | -29,623 (-3.07%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 0.90% | 342,896 | +30,829 (+8.99%) | Feb 28, 2026 |
ROYCE FUND | 0.53% | 200,000 | +200,000 (+100.00%) | Mar 31, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.46% | 175,775 | +68,858 (+39.17%) | Feb 28, 2026 |
SCHWAB CAPITAL TRUST | 0.26% | 100,077 | +42,772 (+42.74%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions56.1M (57.18%)
- Insiders25.2M (25.69%)
- Mutual Funds16.8M (17.14%)
- Other0 (0.00%)
Insider Transactions
- 25.69% (25.2M)Current InsiderOwnership (%, shares)
- 5Number of InsiderBuying (last 12 months)
- $10.2MAmount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $12.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Stansky Michael P | Buy | May 15, 2026 | $1.0M | 410,000 | $2.50 | 1.2M |
Szela Mary T CEO and President | Buy | May 15, 2026 | $102,776.38 | 39,682 | $2.59 | 1.1M |
Wahlstrom Mats | Buy | May 15, 2026 | $151,800.00 | 60,000 | $2.53 | 147,555 |
Patience David Chief Financial Officer | Buy | May 15, 2026 | $17,253.00 | 7,100 | $2.43 | 275,757 |
Stansky Michael P | Buy | May 15, 2026 | $500,000.00 | 200,000 | $2.50 | 399,698 |
Gordon Gary B. | Award | May 14, 2026 | $0.00 | 56,403 | $0.00 | 112,653 |
MATLIN DAVID J | Award | May 14, 2026 | $0.00 | 56,403 | $0.00 | 121,403 |
Valle William | Award | May 14, 2026 | $0.00 | 56,403 | $0.00 | 112,653 |
Wahlstrom Mats | Award | May 14, 2026 | $0.00 | 75,204 | $0.00 | 276,149 |
Gordon Gary B. | Award | May 14, 2026 | $0.00 | 28,201 | $0.00 | 37,957 |
MATLIN DAVID J | Award | May 14, 2026 | $0.00 | 28,201 | $0.00 | 1.3M |
Valle William | Award | May 14, 2026 | $0.00 | 28,201 | $0.00 | 58,688 |
Stansky Michael P | Award | May 14, 2026 | $0.00 | 47,003 | $0.00 | 139,540 |
Gordon Gary B. | Award | May 14, 2026 | $0.00 | 24,553 | $0.00 | 62,510 |
MATLIN DAVID J | Award | May 14, 2026 | $0.00 | 23,065 | $0.00 | 1.3M |
Valle William | Award | May 14, 2026 | $0.00 | 24,553 | $0.00 | 83,241 |
Wahlstrom Mats | Award | May 14, 2026 | $0.00 | 37,602 | $0.00 | 53,329 |
Stansky Michael P | Award | May 14, 2026 | $0.00 | 23,501 | $0.00 | 810,633 |
Wahlstrom Mats | Award | May 14, 2026 | $0.00 | 34,226 | $0.00 | 87,555 |
Stansky Michael P | Award | May 14, 2026 | $0.00 | 20,089 | $0.00 | 830,722 |
Szela Mary T CEO and President | Sell | Mar 17, 2026 | $61,384.40 | 15,944 | $3.85 | 752,987 |
Cox Bryan F. Chief of Research | Sell | Mar 16, 2026 | $2,385.48 | 579 | $4.12 | 163,415 |
Stevens Jennifer Chief Regulatory Officer | Sell | Mar 16, 2026 | $3,188.88 | 774 | $4.12 | 124,110 |
Devlin Jodi Chief of Clinical Operations | Sell | Mar 16, 2026 | $1,124.76 | 273 | $4.12 | 97,364 |
Marshak Richard Chief Commercial Officer | Sell | Mar 16, 2026 | $1,726.28 | 419 | $4.12 | 110,397 |
Cox Bryan F. Chief of Research | Sell | Mar 12, 2026 | $6,000.03 | 1,467 | $4.09 | 163,994 |
Stevens Jennifer Chief Regulatory Officer | Sell | Mar 12, 2026 | $6,347.68 | 1,552 | $4.09 | 124,884 |
Devlin Jodi Chief of Clinical Operations | Sell | Mar 12, 2026 | $7,247.48 | 1,772 | $4.09 | 97,637 |
Marshak Richard Chief Commercial Officer | Sell | Mar 12, 2026 | $6,499.01 | 1,589 | $4.09 | 110,816 |
Cox Bryan F. Chief of Research | Sell | Mar 11, 2026 | $4,699.94 | 1,138 | $4.13 | 165,461 |